New clinical tests for managing autoimmune treatments.
Autoimmune disease treatments are often chosen without reliable prediction of which therapy will work for a given patient, leading to non-response and unmet clinical need.
Coral Genomics develops clinical laboratory tests that integrate molecular, functional, and clinical data to predict optimal autoimmune therapies and identify non-responders.
Clinicians and healthcare systems treating autoimmune patients, via clinical laboratories that run the tests.
PhD from MIT and researched at Broad Institute




